Get the Right Message to the Right Patients

MyTherapy Campaign Engine

The MyTherapy Campaign Engine is designed to help pharma reach highly targeted patient communities with its activation, education, and awareness campaigns. The Campaign Engine takes advantage of MyTherapy’s large and diverse user base to allow our partners to push content to precise user groups, such as those with certain medications scheduled, resulting in remarkable levels of engagement and measurable patient activation.

MyTherapy Campaign Engine for Rx campaigns

We work with partners in the pharmaceutical industry to run Rx campaigns on a range of topics, from the importance of vaccinations among vulnerable patients to raising awareness of innovative treatments. Our in-house editorial team helps pharma achieve engaging content that is globally compliant, driving patient activation and supporting patients in taking more educated and informed treatment decisions.

How the MyTherapy Campaign Engine works for pharmaceutical-grade/OTC products

Producers of pharmaceutical-grade (or medical-grade) or over-the-counter products can also benefit from this precision targeting. Many products are particularly valuable for certain patient populations, such as skin creams for patients living with conditions such as psoriasis or eczema. The MyTherapy Campaign Engine allows producers of these products to reach patient communities with tailored messaging.

Want to see it in action?

Request a demo

Other services

Patient Support

MyTherapy is the OS for pharma’s digital patient support, with tailored modules running on the core platform to bring value to pharma and patients.

Learn more

SaMD, DTx, & IoT

MyTherapy also acts as the OS for digital therapeutics thanks to smartpatient meeting industry standards, such as maintaining an ISO-13485-certified QMS.

Learn more

RWE, Data, & Surveys

smartpatient Insights is a dedicated brand for delivering pharma real-world evidence and data insights. Understand patient journeys and run custom surveys among targeted patient populations.

Learn more